Respiratory Insufficiency: Clinical Trials

16 trials for Respiratory Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 unknown. 16 Phase 2, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Unknown 16
Phase 34Unknown 4

Follow Respiratory Insufficiency: new trials by email Literature Review of Respiratory Insufficiency trials Research Report on Respiratory Insufficiency

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
MRG-001 (Low-dose), MRG-001 (High-dose), Placebo - Acute Respiratory Distress Syndrome, Respiratory Failure
Phase 2UnknownMedRegen LLC602024-12-012024-08-23
Biological Effects of Quercetin in COPD Phase II
Quercetin 1000 mg, Quercetin 500 MG, Placebo - Chronic Obstructive Pulmonary Disease, Emphysema
Phase 2UnknownTemple University302023-11-012024-04-08
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure
Phase 2 / Phase 3UnknownErasme University Hospital602021-12-302021-08-02
High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery
High flow nasal cannula, CONTROL - Chronic Obstructive Pulmonary Disease, Respiratory Failure
Phase 2UnknownAlexandria University602020-08-012020-08-20
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
Standard of Care (SOC) + ANG-3777, Standard Of Care (SOC) + Placebo - COVID-19, Pneumonia
Phase 2UnknownAngion Biomedica Corp1002020-07-312021-04-15
Hemostasis in COVID-19: an Adaptive Clinical Trial
acetylsalicylic acid, Unfractionated heparin nebulized - COVID-19
Phase 2UnknownUniversity of Sao Paulo General Hospital3792020-07-112021-06-09
Airway Clearance Using Non-Invasive Oscillating Device
NIOD Frequencer - Respiratory Insufficiency
Phase 2 / Phase 3UnknownSt. Justine's Hospital202020-06-012020-03-17
Immunoregulatory Therapy for 2019-nCoV
PD-1 blocking antibody+standard treatment, Thymosin+standard treatment, standard treatment - 2019 nCoV, PD-1
Phase 2UnknownSoutheast University, China1202020-02-102020-02-13
Fluid Restriction Keeps Children Dry
Restrictive fluid regimen, Liberal fluid regimen - Respiratory Infection, Fluid Overload
Phase 2 / Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)342016-09-012016-12-12
Non-invasive Measurements of Elastance and Resistance
Invasive method, Non invasive method - Respiratory Insufficiency
Phase 2UnknownUniversity of Turin, Italy152012-02-012012-02-09
Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation
Mechanical Ventilation - Respiratory Failure, Acute Lung Injury (ALI)
Phase 2UnknownIntermountain Health Care, Inc.2462011-10-012015-08-26
Strategies to Optimize Positive End-expiratory Pressure (PEEP) in Patients With Acute Lung Injury
PEEP titration - Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 2UnknownUniversity Hospital, Bonn402011-03-012011-03-30
Comparison Between High-flow Nasal Cannula System and Non-invasive Ventilation in Acute Hypoxemic Respiratory Failure
Non-invasive ventilation, High flow nasal cannula system - Acute Hypoxemic Respiratory Failure
Phase 2 / Phase 3UnknownAsan Medical Center742010-07-012010-07-21
Negative Pressure Ventilation Imapcts Weaning Ventilator In Medical Intensive Care Units (ICUs)
negative pressure ventilator use - Respiratory Failure
Phase 2UnknownChang Gung Memorial Hospital1202010-03-012010-07-02
Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults
dexamethasone (Oradexon, Nederland) - Airway Obstruction
Phase 2UnknownMackay Memorial Hospital802007-04-012008-05-28
Dexamethasone and the Prevention of Post-Extubation Airway Obstruction in Adults
Dexamethasone - Airway Obstruction
Phase 2UnknownMackay Memorial Hospital702004-10-012007-03-26

Narrower conditions

Respiratory Distress Syndrome (4)  ·  Acute Lung Injury (3)  ·  Airway Obstruction (3)  ·  COVID-19 (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Coronavirus Infections (1)  ·  Critical Illness (1)  ·  Cytokine Release Syndrome (1)  ·  Edema (1)  ·  Emphysema (1)  ·  Hemostatic Disorders (1)  ·  Laryngeal Edema (1)  ·  Parkinson Disease 4, Autosomal Dominant Lewy Body (1)  ·  Pneumonia (1)

Broader conditions

Respiration Disorders (16)  ·  Respiratory Tract Diseases (15)  ·  Lung Diseases (7)  ·  Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Coronaviridae Infections (3)  ·  Disease Attributes (3)  ·  Lung Injury (3)  ·  Nidovirales Infections (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Chronic Disease (2)  ·  Coronavirus Infections (2)

Interventions

Dexamethasone (2)  ·  Aspirin (1)  ·  Noninvasive Ventilation (1)  ·  Quercetin (1)  ·  Respiration, Artificial (1)  ·  Standard of Care (1)  ·  angiotensin I (1-7) (1)  ·  terevalefim (1)

Sponsors

Mackay Memorial Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Alexandria University (1)  ·  Angion Biomedica Corp (1)  ·  Asan Medical Center (1)  ·  Chang Gung Memorial Hospital (1)  ·  Erasme University Hospital (1)  ·  Intermountain Health Care, Inc. (1)  ·  MedRegen LLC (1)  ·  Southeast University, China (1)  ·  St. Justine's Hospital (1)  ·  Temple University (1)  ·  University Hospital, Bonn (1)  ·  University of Sao Paulo General Hospital (1)  ·  University of Turin, Italy (1)

Countries

Taiwan (3)  ·  Brazil (2)  ·  United States (2)  ·  Egypt (1)  ·  Germany (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Chao-Hsien Lee, MD (2)  ·  Atsushi Kawaguchi (1)  ·  Chae-Man Lim, M.D. (1)  ·  Christian Putensen, MD, Prof (1)  ·  Eliotte Hirshberg, MD (1)  ·  Filippo Annoni, MD (1)  ·  Gordon R Bernard, MD (1)  ·  John Neylan, MD (1)  ·  Nathaniel Marchetti (1)  ·  Rehab A. Abd Elaziz, Ass.Prof. (1)  ·  Robson AS Santos, MD,PhD (1)  ·  Thomas Muders, MD (1)  ·  Vanderson Rocha (1)

Results publications

PMID 15141377, PMID 16424722, PMID 16540947, PMID 17605780, PMID 20920189, PMID 20937093, PMID 22315264, PMID 22465313, PMID 23849147, PMID 23919993, PMID 24038922, PMID 29264361, PMID 29975735, PMID 31921715, PMID 31986264, PMID 32071149, PMID 32142651, PMID 32155444, PMID 32192578, PMID 32212240, PMID 32227760, PMID 32246450, PMID 32271988, PMID 32275452, PMID 32283155, PMID 32291094, PMID 32291954, PMID 32294295, PMID 32302438, PMID 32302462, PMID 32305740, PMID 32311448, PMID 32320517, PMID 32329246, PMID 32353746, PMID 32367170, PMID 32369666, PMID 32387623, PMID 32437596, PMID 32445064, PMID 32450344, PMID 32459672, PMID 32462179, PMID 32469410, PMID 33020101, PMID 37633275, PMID 8874303

NIH funding

R33AT009991 (1)